Graham Capital Management’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,469
| Closed | -$239K | – | 1205 |
|
|
2024
Q1 | $239K | Buy |
15,469
+7,404
| +92% | +$115K | ﹤0.01% | 828 |
|
|
2023
Q4 | $226K | Sell |
8,065
-2,277
| -22% | -$63.8K | 0.01% | 780 |
|
|
2023
Q3 | $492K | Buy |
10,342
+9,098
| +731% | +$433K | 0.01% | 553 |
|
|
2023
Q2 | $119K | Buy |
+1,244
| New | +$119K | ﹤0.01% | 866 |
|
|
2022
Q4 | – | Sell |
-5,307
| Closed | -$681K | – | 1198 |
|
|
2022
Q3 | $681K | Sell |
5,307
-7,120
| -57% | -$914K | 0.03% | 631 |
|
|
2022
Q2 | $852K | Buy |
12,427
+7,058
| +131% | +$484K | 0.03% | 485 |
|
|
2022
Q1 | $764K | Sell |
5,369
-102
| -2% | -$14.5K | 0.03% | 392 |
|
|
2021
Q4 | $911K | Buy |
+5,471
| New | +$911K | 0.04% | 95 |
|